These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5062118)

  • 1. Comparison of galanthamine with neostigmine for reversal of d-tubocurarine neuromuscular blockade in man.
    De Angelis J; Walts LF
    Anesth Analg; 1972; 51(2):196-9. PubMed ID: 5062118
    [No Abstract]   [Full Text] [Related]  

  • 2. Galanthamine versus neostigmine for reversal of nondepolarizing neuromuscular block in man.
    Baraka A; Cozanitis D
    Anesth Analg; 1973; 52(5):832-6. PubMed ID: 4738207
    [No Abstract]   [Full Text] [Related]  

  • 3. The potency ratio of galanthamine and neostigmine on the reversal of the tubocurarine block in the isolated rat diaphragm.
    Cozanitis DA
    Acta Anaesthesiol Belg; 1977; 28(2):53-60. PubMed ID: 201139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies involving neostigmine reversal of d-tubocurarine, gallamine, and pancuronium in man.
    De Angelis J
    Anesth Analg; 1974; 53(2):268-70. PubMed ID: 4856137
    [No Abstract]   [Full Text] [Related]  

  • 5. [Galanthamine as an antagonist of succinylcholine and tubocurarine in cancer patients].
    Gadalov VP; Khmelevskiĭ IaM
    Vestn Akad Med Nauk SSSR; 1974; (12):13-9. PubMed ID: 4446704
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of neuromuscular blockade with a mixture of neostigmine and glycopyrrolate.
    Klingenmaier CH; Bullard R; Thompson D; Watson R
    Anesth Analg; 1972; 51(3):468-72. PubMed ID: 5064029
    [No Abstract]   [Full Text] [Related]  

  • 7. Neostigmine reversal of D-tubocurarine and pancuronium bromide combinations in man.
    Frankel DZ
    Can Anaesth Soc J; 1982 Jul; 29(4):395-7. PubMed ID: 7104811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Galanthamine (nivaline) as an antidote for nondepolarizing myorelaxants].
    Kovanev VA; Khmelevskiĭ IaM; Ganina SS
    Eksp Khir Anesteziol; 1967; 12(4):65-9. PubMed ID: 5617077
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of divided doses of neostigmine on the dynamics of decurarization.
    Potocki B; Niewinska J; Borucki Z
    Anaesth Resusc Intensive Ther; 1975; 3(3):238-45. PubMed ID: 1217695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of gallamine and pancuronium with tubocurarine under morphine-nitrous oxide-oxygen anesthesia in man.
    Park WY; Balingit PE; Macnamara TE
    Anesth Analg; 1974; 53(5):723-9. PubMed ID: 4472154
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to tubocurarine chloride and its reversal by neostigmine methylsulfate in man.
    Bridenbaugh PO; Churchll-Davidson HC
    JAMA; 1968 Feb; 203(8):541-4. PubMed ID: 5694188
    [No Abstract]   [Full Text] [Related]  

  • 12. Experiences with galanthamine hydrobromide as curare antagonist.
    Cozanitis DA
    Anaesthesist; 1971 Jun; 20(6):226-9. PubMed ID: 4256926
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation between neostigmine and 3,4-diaminopyridine in antagonizing the neuromuscular block induced by D-tubocurarine.
    Chang CC; Su MJ; Shieh BH; Lin HL; Hong SJ
    Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):235-9. PubMed ID: 6100937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between anticurare activity of tetanic stimulation and neostigmine in anesthetized man.
    Stanec A; Stanec G; Baker T
    Anesth Analg; 1981 Apr; 60(4):175-81. PubMed ID: 6452072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuromuscular pharmacology of neostigmine in infants and children.
    Fisher DM; Cronnelly R; Miller RD; Sharma M
    Anesthesiology; 1983 Sep; 59(3):220-5. PubMed ID: 6309036
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relaxometric investigations of galanthamine as an antidote to pancuronium. The technique of relaxometry (author's transl)].
    Foitzik H; Lawin P; Wittkemper C
    Z Prakt Anasth Wiederbeleb Intensivther; 1973 Jan; 8(1):18-24. PubMed ID: 4768767
    [No Abstract]   [Full Text] [Related]  

  • 17. [The antimyorelaxant effect of cholinopotentiating drugs].
    Prozorovskiĭ VB; Vladeeva NV; Khromova ON; Dubovitskaia SI
    Biull Eksp Biol Med; 1970 Jun; 69(6):51-4. PubMed ID: 4248601
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of galanthamine hydrobromide and atropine-neostigmine in conscious volunteers.
    Cozanitis DA; Toivakka E
    Anaesthesist; 1971 Nov; 20(11):416-21. PubMed ID: 5126442
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonism of d-tubocurarine-induced neuromuscular blockade with a mixture of 4-aminopyridine and neostigmine in man.
    Wirtavuori K; Salmenperä M; Tammisto T
    Can Anaesth Soc J; 1984 Nov; 31(6):624-30. PubMed ID: 6093961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antagonistic effects of neostigmine, 4-aminopyridine and 3,4-diaminopyridine on muscle relaxing effects of d-tubocurarine].
    Fukushima K; Aoki T; Ishikawa J
    Masui; 1983 Oct; 32(10):1236-40. PubMed ID: 6668654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.